Hereditary gastrointestinal syndromes and genetic disorders play a critical role in cancer predisposition, inflammatory conditions, and congenital GI abnormalities. Advances in genetic testing, next-generation sequencing, and molecular diagnostics have transformed early detection and risk assessment. Identifying pathogenic variants enables targeted surveillance, preventive strategies, and personalized treatment plans. Genetic counseling and family-based screening are essential components of comprehensive care. Research continues to uncover novel genetic pathways influencing disease susceptibility and progression. This topic focuses on integrating genetics into clinical gastroenterology, highlighting advances in precision medicine, ethical considerations, and the role of genomics in improving long-term outcomes.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy